DR. Joris Callens SRL
DR. Joris Callens reported total assets of 564,985 € at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Jul 2026).
The score of DR. Joris Callens shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +98 % Total assets -30 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DR. Joris Callens's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 146,397 € | ||||
| Equity | 484,960 € | ||||
| Cash | 166,758 € | ||||
| EBITDA | 230,716 € | ||||
| Total assets | 564,985 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jul 2026
- Year ended 31 Dec 2024filed on 14 Jul 2025
- Year ended 31 Dec 2023filed on 25 Jul 2024
- Year ended 31 Dec 2022filed on 26 Jul 2023
- Year ended 31 Dec 2021filed on 19 Jul 2022
DR. Joris Callens's financial analysis
- Solvency85.8%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DR. Joris Callens
DR. Joris Callens's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0890.684.385
- VAT number
- BE0890684385
- Peppol
- Registered · 0208:0890684385 · as of 11 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Jul 2007
- Registered office
- 8300 Knokke-Heist
- Latest accounts
- 2025 · filed on 15 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
DR. Joris Callens (SRL) has been based in Knokke-Heist since 2007, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 146,397 € and equity of 484,960 €; its revenue is not published. Its solvency stands at 85.8%, above the median of its sector (60.4%).
Companies similar to DR. Joris Callens
Companies in the same business, of comparable size and area, outside its group.
- NanoBiotech Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 1,834 €
- DES Grottes-Oleffe Comedic Research and experimental development on natural sciences and engineering La Hulpe · balance sheet 573,577 €
- Feron Gautier Research and experimental development on natural sciences and engineering Ath · balance sheet 673,953 €
- Docteur Christophe TOMBEUX - Cardiologie Research and experimental development on natural sciences and engineering Ferrières · balance sheet 645,314 €
- Rhumat-OS Research and experimental development on natural sciences and engineering Waterloo · balance sheet 658,861 €
- Alba3 Research and experimental development on natural sciences and engineering Ottignies-Louvain-la-Neuve · balance sheet 660,076 €
- Dokter Sara Van Soom, huisarts Research and experimental development on natural sciences and engineering Edegem · balance sheet 477,219 €
- IndusFilter Research and experimental development on natural sciences and engineering Ghent · balance sheet 443,685 €
Frequently asked questions about DR. Joris Callens
What is the revenue of DR. Joris Callens?
DR. Joris Callens files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of DR. Joris Callens?
In Belgium, the VAT number is the company number prefixed with BE: BE0890684385 for DR. Joris Callens, if the company is VAT-registered. Its company number (CBE) is 0890.684.385.
Where is the registered office of DR. Joris Callens?
According to the CBE register, the registered office of DR. Joris Callens is in 8300 Knokke-Heist.
What is the equity of DR. Joris Callens?
At the close of the 2025 financial year, the equity of DR. Joris Callens amounts to 484,960 €, a solvency of 85.8% of total assets.
Who manages DR. Joris Callens?
The register lists 1 active mandates at DR. Joris Callens. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of DR. Joris Callens
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →